Gérard Soula CEO Adocia : " We assemble all the pieces for the Ultra -fast".
Strategy and perspectives for 2016

7 janvier 2016 18 h 53 min
+ de videos
255
Views
Loading the player...

Web TV www.labourseetlavie.com partner of Oddo Forum 2016 held in Lyon on 7 and 8 January met many leaders to talk about the year 2015 and 2016 outlook . Back to news biotechnology company specializing in the development of innovative protein formulations.

My guest to discuss the strategy is Gérard Soula CEO Adocia .

Print Friendly, PDF & Email

Articles associés :

  1. Professeur Hartmut Ehrlich CEO ABIVAX : “Nous allons démarrer la phase finale du développement clinique de notre vaccin thérapeutique contre l’hépatite B chronique” : Biotech : nouvelle introduction en Bourse pour la société Abivax sur Euronext Paris
  2. Judith Greciet CEO Onxeo : “It’s really in our core strategy” : Acquisition DNA Therapeutics
  3. Pascal Imbert Chairman of The Management Board Solucom : “The new growth cycle is now open “ : Strategy and perspectives 2016
  4. Eric Matteucci Chairman of The Management Board SII : “We remain confident in the improved results of the group”

Related Videos

interview-michel-denis-president-et-ceo-manitou-13-janvier-2021

Michel Denis President & CEO Manitou : “We’ll deliver”

interview-eric-matteucci-president-du-directoire-sii-sur les résultats-semestriels-2015-2016

Eric Matteucci Chairman of The Management Board SII : “We remain confident in the improved results of the group”

00066626-be2bef1e9ea79133ee83a970960c2c12

Professeur Hartmut Ehrlich CEO ABIVAX : “Nous allons démarrer la phase finale du développement clinique de notre vaccin thérapeutique contre l’hépatite B chronique”

Nicolas Valtille CFO Akka Technologies

Nicolas Valtille CFO Akka Technologies : “A group able to take global projects”